“…HEK-293, COS-7 and SH-SY5Y cells (5 × 10 4 cells/well of a 24-well plate) were transfected with 200 ng/well BAT-gal plasmid [Addgene plasmid 20889 (Maretto et al, 2003)] using Lipofectamine 2000 and fixed after 24 h for ICC. Using Lipofectamine 2000 or TurboFect Transfection Reagent (Thermo Fisher Scientific), 5 × 10 4 or 2 × 10 5 HEK-293 cells/well of a 24-well plate were co-transfected with 200 ng/well of each reporter construct [Super8xTOPFlash or Super8xFOPFlash (Lie et al, 2005), or a wild-type or mutagenized 2514 bp mouse Pitx3 promoter fragment (-2425 to +89) in pGL3 basic vector (Peng et al, 2011)], 0.1 ng/well pRL-SV40 (Promega) internal transfection control and pcDNA3.1 (Thermo Fisher Scientific) "empty" vector to adjust for DNA content; alone or together with 200 ng/well or varying amounts of stabilized pcDNA3-S33Y b-catenin [Addgene plasmid 19286, (Kolligs et al, 1999)] with or without 200 ng/well or varying amounts of human LEF1 cDNA (Waterman et al, 1991), and vice versa, 166 ng/well pMES-Lmx1a-IRES-eGFP (Klafke et al, 2016), or 353.8 ng/well LMX1A siRNA (#144, Supplementary Table 1). The human LEF1 cDNA comprises the 399 aa ORF of full-length human LEF1 protein (including the N-terminal b-catenin binding domain) and was confirmed by sequencing (SEQLAB GmbH, Göttingen, Germany).…”